Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Wampler

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|July 1, 1985
Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapyM Eleff, P E Franks, G L Wampler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program studyG L Wampler, W J Heim, N M Ellison, et al.
American Journal of Clinical Oncology|October 1, 1991
Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP studyG L Wampler, J D Ahlgren, J J Lokich, et al.
Advances in Enzyme Regulation|January 1, 1980
Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsH L Elford, B Van't Riet, G L Wampler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program StudyM Auerbach, G L Wampler, J J Lokich, et al.
Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.
American Journal of Clinical Oncology|February 1, 1992
A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer. A Mid-Atlantic Oncology Program studyC J Rosenthal, G L Wampler, H D Brereton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancerJ D Hainsworth, N Levitan, G L Wampler, et al.
Cancer|January 1, 1991
A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program studyJ J Lokich, J D Ahlgren, J Cantrell, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moietiesM E Perlman, J A Dunn, T A Piscitelli, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|July 1, 1985
Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapyM Eleff, P E Franks, G L Wampler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Comparison of cyclophosphamide, doxorubicin, and vincristine with an alternating regimen of methotrexate, etoposide, and cisplatin/cyclophosphamide, doxorubicin, and vincristine in the treatment of extensive-disease small-cell lung carcinoma: a Mid-Atlantic Oncology Program studyG L Wampler, W J Heim, N M Ellison, et al.
American Journal of Clinical Oncology|October 1, 1991
Dichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP studyG L Wampler, J D Ahlgren, J J Lokich, et al.
Advances in Enzyme Regulation|January 1, 1980
Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsH L Elford, B Van't Riet, G L Wampler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Treatment of advanced pancreatic carcinoma with a combination of protracted infusional 5-fluorouracil and weekly carboplatin: a Mid-Atlantic Oncology Program StudyM Auerbach, G L Wampler, J J Lokich, et al.
Cancer Treatment Reports|July 1, 1978
Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancerR G Hahn, N R Temkin, E D Savlov, et al.
American Journal of Clinical Oncology|February 1, 1992
A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer. A Mid-Atlantic Oncology Program studyC J Rosenthal, G L Wampler, H D Brereton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II randomized study of cisplatin plus etoposide phosphate or etoposide in the treatment of small-cell lung cancerJ D Hainsworth, N Levitan, G L Wampler, et al.
Cancer|January 1, 1991
A prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program studyJ J Lokich, J D Ahlgren, J Cantrell, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis of potential dual-acting radiation sensitizer antineoplastic agents: 2,2-dimethylphosphoraziridines containing 2-nitroimidazoles or other electron-affinic moietiesM E Perlman, J A Dunn, T A Piscitelli, et al.
Pageof 6